Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-06T23:30:40.948Z Has data issue: false hasContentIssue false

Curcumin alleviates eosinophilic meningitis through reduction of eosinophil count following albendazole treatment against Angiostrongylus cantonensis in mice

Published online by Cambridge University Press:  07 November 2011

LING-YUH SHYU*
Affiliation:
Institute of Medicine, Chung Shan Medical University, Taiwan, ROC Department of Parasitology, Chung Shan Medical University, Taiwan, ROC
HAN-HSIN CHANG
Affiliation:
School of Nutrition, Chung Shan Medical University, Taiwan, ROC
JENG-DONG HSU
Affiliation:
Department of Pathology, Chung Shan Medical University, Taiwan, ROC
DAVID PEI-CHENG LIN
Affiliation:
School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taiwan, ROC
YING-HOCK TENG
Affiliation:
Institute of Medicine, Chung Shan Medical University, Taiwan, ROC Chung Shan Medical University, Department of Emergency Medicine, Taiwan, ROC
HSIU-HSIUNG LEE
Affiliation:
Institute of Medicine, Chung Shan Medical University, Taiwan, ROC Department of Parasitology, Chung Shan Medical University, Taiwan, ROC
*
*Corresponding author: Chung Shan Medical University, Department of Parasitology, Taiwan, ROC, 110, Sec. 1, Jianguo N. Road., Taichung City 402, Taiwan. Tel: +886 4 24730022 ext 11642. Fax: 886-4-24714143. E-mail: sly@csmu.edu.tw
Rights & Permissions [Opens in a new window]

Summary

Angiostrongylus cantonensis (A. cantonensis) is the most common cause of parasitic eosinophilic meningitis worldwide. By using an animal model of BALB/c mice infected with A. cantonensis, previous studies indicated that the anthelmintic drug, albendazole, could kill A. cantonensis larvae and prevent further infection. However, the dead larvae will induce severe immune responses targeting at brain tissues. To alleviate the detrimental effects caused by the dead larvae, we administered curcumin, a traditional anti-inflammatory agent, as a complementary treatment in addition to albendazole therapy, to determine whether curcumin could be beneficial for treatment. The results showed that although curcumin treatment alone did not reduce worm number, combined treatment by albendazole and curcumin helped to reduce eosinophil count in the cerebrospinal fluid, better than using albendazole alone. This alleviating effect did not affect albendazole treatment alone, since histological analysis showed similar worm eradication with or without addition of curcumin. Nevertheless, curcumin treatment alone and combined albendazole-curcumin treatment did not inhibit MMP-9 expression in the brain tissue. In conclusion, curcumin, when used as a complementary treatment to albendazole, could help to alleviate eosinophilic meningitis through suppression of eosinophil count in the cerebrospinal fluid.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2011
Figure 0

Fig. 1. Brain worm number on day 21 after infection was used for the assessment of anthelmintic efficacy in the study groups. The worms were almost eradicated in albendazole alone and albendazole-curcumin combined groups, in contrast to the high worm number in the untreated group. Using curcumin alone did not reduce worm number (P=0·67). Combined albendazole-curcumin treatment did not add to the anthelmintic efficacy (p=0·68), as compared with treatment by albendazole alone.

Figure 1

Fig. 2. Eosinophil counts in CSF in the study groups on day 21 after infection. All the eosinophil counts were significantly higher than the uninfected control group. The eosinophil counts were significantly reduced with albendazole treatment alone (P=0·03) and with combined albendazole-curcumin treatment (P=0·005), as compared to that of the untreated group. Curcumin treatment alone did not reduce eosinophil counts (P=0·119). However, the combined albendazole-curcumin treatment was more effective in reducing the eosinophil count than albendazole treatment alone (P=0·03).

Figure 2

Fig. 3. Histopathological changes and immunohistochemical detection of MMP-9 expression in mice cerebellums on day 21 after infection. (A)–(E) Haematoxylin-eosin stain. (A) Specimen from the untreated group showing a worm in the cerebellum (indicated by an arrowhead). (B) Specimen from the infected group with albendazole treatment alone showing no worm. (C) A worm remained detected (indicated by arrowhead) in the infected mouse cerebellum treated with curcumin alone. (D) No worm was found in the infected mice with combined albendazole-curcumin treatment. (E) Uninfected control mouse without any treatment. (a)–(e) Immunohistochemistry for MMP-9 expression in the cerebellums. Stronger MMP-9 expression was detected in the infected mice without any treatment (3a) and in infected mice treated with curcumin alone (3c).

Figure 3

Fig. 4. Gelatin zymography analysis of MMP-9 activity. MMP-9 activity was not detected in the control group (lane 1), but was induced with Angiostrongylus cantonensis infection without treatment (lane 2) or with curcumin treatment alone (lane 4). On the contrary, albendazole treatment alone (lane 3) or combined albendazole- curcumin treatment (lane 5) completely inhibited the MMP-9 activity. MMP-2 activity was not detected in all study groups.

Figure 4

Fig. 5. Semi-quantitative analysis of MMP-9 activity by scanning gelatin-zymogram bands. The results showed a significant suppression of MMP-9 activity in the infected mouse brain with albendazole treatment alone (P=0·029) or with combined albendazole-curcumin treatment (P=0·027), when compared with that of the untreated group. Curcumin treatment alone did not exert a significant inhibitory effect on MMP-9 activity as compared to the untreated group (P=0·372).